BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3827691)

  • 1. Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging.
    Starosta-Rubinstein S; Young AB; Kluin K; Hill G; Aisen AM; Gabrielsen T; Brewer GJ
    Arch Neurol; 1987 Apr; 44(4):365-70. PubMed ID: 3827691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cranial MR imaging in Wilson's disease.
    King AD; Walshe JM; Kendall BE; Chinn RJ; Paley MN; Wilkinson ID; Halligan S; Hall-Craggs MA
    AJR Am J Roentgenol; 1996 Dec; 167(6):1579-84. PubMed ID: 8956601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cranial MRI in Wilson's disease.
    Prayer L; Wimberger D; Kramer J; Grimm G; Oder W; Imhof H
    Neuroradiology; 1990; 32(3):211-4. PubMed ID: 2215906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional morphometric abnormalities and clinical relevance in Wilson's disease.
    Zou L; Song Y; Zhou X; Chu J; Tang X
    Mov Disord; 2019 Apr; 34(4):545-554. PubMed ID: 30817852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High field magnetic resonance imaging in Wilson's disease].
    Hitoshi S; Nangaku M; Shimada H; Yamada H; Yoshikawa H; Iwata M
    Rinsho Shinkeigaku; 1990 Feb; 30(2):139-45. PubMed ID: 2350924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cerebral magnetic resonance in Wilson's disease].
    Amato C; Bisceglie P; Moschini M
    Radiol Med; 1994 Dec; 88(6):752-7. PubMed ID: 7878232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wilson's disease: two treatment modalities. Correlations to pretreatment and posttreatment brain MRI.
    da Costa Mdo D; Spitz M; Bacheschi LA; Leite CC; Lucato LT; Barbosa ER
    Neuroradiology; 2009 Oct; 51(10):627-33. PubMed ID: 19479249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological Wilson's disease studied with magnetic resonance imaging and with positron emission tomography using dopaminergic markers.
    Westermark K; Tedroff J; Thuomas KA; Hartvig P; Långström B; Andersson Y; Hörnfeldt K; Aquilonius SM
    Mov Disord; 1995 Sep; 10(5):596-603. PubMed ID: 8552111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The asymmetry of neural symptoms in Wilson's disease patients detecting by diffusion tensor imaging, resting-state functional MRI, and susceptibility-weighted imaging.
    Zhou XX; Li XH; Chen DB; Wu C; Feng L; Chu JP; Yang ZY; Li XB; Qin H; Li GD; Huang HW; Liang YY; Liang XL
    Brain Behav; 2018 May; 8(5):e00930. PubMed ID: 29761003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible magnetic resonance imaging lesions in Wilson's disease: clinical-anatomical correlation.
    Takahashi W; Yoshii F; Shinohara Y
    J Neuroimaging; 1996 Oct; 6(4):246-8. PubMed ID: 8903079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute dystonia with thalamic and brainstem lesions after initial penicillamine treatment in Wilson's disease.
    Huang CC; Chu NS
    Eur Neurol; 1998; 39(1):32-7. PubMed ID: 9476721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of brain MRI characteristics and clinical features in 76 cases of Wilson's disease.
    Zhong W; Huang Z; Tang X
    J Clin Neurosci; 2019 Jan; 59():167-174. PubMed ID: 30385165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wilson's disease: contrast enhancement of cerebral lesions on MR images after penicillamine therapy.
    Sener RN
    AJR Am J Roentgenol; 1994 Jul; 163(1):228-9. PubMed ID: 8010238
    [No Abstract]   [Full Text] [Related]  

  • 14. Wilson's disease: MRI with clinical correlation.
    Magalhaes AC; Caramelli P; Menezes JR; Lo LS; Bacheschi LA; Barbosa ER; Rosemberg LA; Magalhaes A
    Neuroradiology; 1994; 36(2):97-100. PubMed ID: 8183467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cranial MR findings in Wilson's disease.
    Saatci I; Topcu M; Baltaoglu FF; Köse G; Yalaz K; Renda Y; Besim A
    Acta Radiol; 1997 Mar; 38(2):250-8. PubMed ID: 9093161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wilson's disease: resolution of MRI lesions following long-term oral zinc therapy.
    Huang CC; Chu NS
    Acta Neurol Scand; 1996; 93(2-3):215-8. PubMed ID: 8741147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wilson's disease: magnetic resonance imaging (MRI) with clinical correlations in 16 cases.
    Barbosa ER; Caramelli P; Bacheschi LA; Haddad MS; Magalhães AC; Menezes JR; Scaff M; Canelas HM
    Rev Paul Med; 1993; 111(3):407-11. PubMed ID: 8108634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wilson's disease: evidence of subgroups derived from clinical findings and brain lesions.
    Oder W; Prayer L; Grimm G; Spatt J; Ferenci P; Kollegger H; Schneider B; Gangl A; Deecke L
    Neurology; 1993 Jan; 43(1):120-4. PubMed ID: 8423874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy.
    Brewer GJ; Terry CA; Aisen AM; Hill GM
    Arch Neurol; 1987 May; 44(5):490-3. PubMed ID: 3579660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metal deposits associated with brain atrophy in the deep gray matter nucleus in Wilson's disease.
    Huang Z; Yang J; Chen D; Zhou X; Xiao X; Wang J; Wang M; Zhao J; Chu J
    Cereb Cortex; 2023 Jul; 33(15):9223-9232. PubMed ID: 37365842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.